Q3 2022 Fulgent Genetics Inc Earnings Call Transcript
Hello, and welcome to the Fulgent Genetics Q3 2022 Earnings Conference Call. (Operator Instructions) As a reminder, this conference is being recorded.
It's now my pleasure to turn the call over to your host, Melanie Solomon, Investor Relations. Please go ahead.
Good afternoon, and welcome to the Fulgent Genetics third quarter 2022 financial results conference call. Today, we will also be discussing the acquisition of Fulgent Pharma announced after the markets closed in a separate press release. On the call are Ming Hsieh, Chief Executive Officer of Fulgent Genetics; Paul Kim, Chief Financial Officer of Fulgent Genetics; Brandon Perthuis, Chief Commercial Officer of Fulgent Genetics; Lawrence Weiss, Chief Medical Officer of Fulgent Genetics; and Dr. Ray Yin, President and Chief Scientific Officer of Fulgent Pharma.
The company's press release discussing these 2 announcements are available on the Investor Relations section of our website, fulgentgenetics.com. The webcast portion of this call
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |